Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis

Concomitant use of multiple antipsychotics to treat Schizophrenia: Risk benefit analysis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022

Podrobná bibliografie
Hlavní autor:	Tabassum, Fariha
Další autoři:	Kalam Azad, Dr. Md. Abul
Médium:	Diplomová práce
Jazyk:	English
Vydáno:	Brac University 2024
Témata:	Schizophrenia Antipsychotics Dopamine Serotonin Glutamate Extrapyramidal side effects
On-line přístup:	http://hdl.handle.net/10361/23879

Podobné jednotky

Utilization of machine learning classifiers to predict different forms of mental illness: schizophrenia, PTSD, bipolar disorder and depression
Autor: Jaman, Ayman Ibn, a další
Vydáno: (2021)

Early Schizophrenia Diagnosis with 3D Convolutional Neural Network
Autor: Ashraf, S.M. Nabil, a další
Vydáno: (2021)

Application of deep learning in MRI classification of Schizophrenia
Autor: Joyee, Ramisa Fariha, a další
Vydáno: (2024)

A review on optogenetics and its potential in neurological disorder management
Autor: Armin, Fariza
Vydáno: (2024)

The divided self : an existential study in sanity and madness /
Autor: Laing, R. D. (Ronald David), 1927-
Vydáno: (1960)

Impact of Lifestyle on the Disease Progression of Parkinson’s
Autor: Annee, Israt Jahan
Vydáno: (2023)

A review on the teratogenic effects of isotretinoin
Autor: Anisha, Tahsina Binte Kashem
Vydáno: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
Autor: Islam, Md. Rakibul
Vydáno: (2023)

Analyzing Schizophrenic-prone text from social media content: a novel approach through ML and NLP
Autor: Rodela, Raisa Rahman, a další
Vydáno: (2024)

Assessment of knowledge and attitude of adverse Ddug reactions among healthcare professionals in Bangladesh
Autor: Paul, Sanjoy Kumer
Vydáno: (2021)

Evaluation of the safety and efficacy of oral isotretinoin in the treatment of acne
Autor: Bose, Ankita
Vydáno: (2024)

Pharmacoepidemiology and pharmacovigilance : synergistic tools to better Investigate drug safety /
Autor: Nour, Sabrina
Vydáno: (2019)

Displaying Ad with Optimal Real-Time Bidding
Autor: Uddin, A F M Ahsan
Vydáno: (2021)

A review of Isotretinoin and its association in affective disorder
Autor: Sarkar, Argha
Vydáno: (2024)

Cost-benefit analysis : concepts and practice /
Vydáno: (2006)

Cost-benefit analysis : issues and methodologies /
Autor: Ray, Anandarup
Vydáno: (1984)

Effect of the nutritional supplements in mental disorders – a review
Autor: Meem, Lamiya Alam
Vydáno: (2021)

Cost-benefit analysis : selected readings /
Vydáno: (1972)

Schizophrenia Bulletin

Schizophrenia Bulletin

Schizophrenia Bulletin

Schizophrenia Bulletin

Schizophrenia Research

Schizophrenia Research

Schizophrenia Bulletin

Detecting Adverse Drug Reaction (ADR) with data mining and predicting its intensity with machine learning
Autor: Hussain, Nadib, a další
Vydáno: (2018)

A review paper on developing novel antiviral strategies against pathogenic RNA viruses
Autor: Nawar, Numia
Vydáno: (2021)

A study on the side effects of Covid-19 vaccines in Bangladesh
Autor: Afrida, Samiha Zaha
Vydáno: (2024)

Permission for dismantling north-east side boundary wall of century center to drive pre-cast piles
Autor: Brac University
Vydáno: (2023)

Treating the Public
Autor: Ball

Treating AIDS
Autor: Sangaramoorthy

Project evaluation criteria and cost-benefit analysis /
Vydáno: (1989)

Schizophrenia Research: Cognition

Schizophrenia | Nature Portfolio

Schizophrenia | Nature Portfolio

Schizophrenia Research: Cognition

Callous disregard : autism and vaccines -- the truth behind a tragedy /
Autor: Wakefield, Andrew J.
Vydáno: (2010)

Perceptions of quality across the maternal care continuum in the context of a health financing intervention: Evidence from a mixed methods study in rural Malawi
Autor: Kambala, Christabel, a další
Vydáno: (2018)

Treating NVLD in Children
Vydáno: (2013)

HPHT-Treated Diamonds
Autor: Dobrinets
Vydáno: (2013)